Terns raises $87M to advance trials of NASH drugs

January 5, 2021 Auto Bot NASH, Pharma, Startups 0

graphic design of a liver

The startup, which licensed three NASH candidates from Eli Lilly, raised $87 million from the drugmaker and Deerfield Management.